INT116859

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.44
First Reported 2004
Last Reported 2011
Negated 4
Speculated 1
Reported most in Body
Documents 15
Total Number 16
Disease Relevance 4.62
Pain Relevance 1.25

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

RNA binding (NOVA2) nucleus (NOVA2)
Anatomy Link Frequency
neurons 1
foot 1
olfactory 1
NOVA2 (Homo sapiens)
Pain Link Frequency Relevance Heat
Central grey 87 97.24 Very High Very High Very High
Eae 19 96.72 Very High Very High Very High
Pain 48 96.68 Very High Very High Very High
visual analogue scale 9 95.64 Very High Very High Very High
acular 25 95.28 Very High Very High Very High
antagonist 17 74.16 Quite High
Dorsal column 6 61.20 Quite High
cINOD 9 60.92 Quite High
monoamine 33 53.52 Quite High
agonist 62 50.00 Quite Low
Disease Link Frequency Relevance Heat
Disease 47 99.32 Very High Very High Very High
Dengue Hemorrhagic Fever 205 97.92 Very High Very High Very High
Urological Neuroanatomy 96 97.24 Very High Very High Very High
Pain 48 96.68 Very High Very High Very High
Injury 23 93.32 High High
Dengue 88 91.44 High High
Infection 31 90.20 High High
Obesity 33 87.72 High High
Shock 35 82.16 Quite High
Gliosis 4 81.16 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
ANOVA: Analysis of Variance

Authors' contributions

Regulation (contributions) of ANOVA
1) Confidence 0.44 Published 2004 Journal BMC Pharmacol Section Body Doc Link PMC526775 Disease Relevance 0 Pain Relevance 0
However, since the effect of the nested factor was found to be insignificant, the data were re-analyzed using a single-factor ANOVA.
Regulation (effect) of ANOVA
2) Confidence 0.44 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2831065 Disease Relevance 0 Pain Relevance 0.05
Factorial ANOVA of aMT6s acrophase responses for all participants demonstrated a highly significant time-of-treatment effect (F5,82 = 15.98, P < 0.0001), confirming a significant PRC.
Regulation (responses) of ANOVA
3) Confidence 0.26 Published 2007 Journal J Circadian Rhythms Section Body Doc Link PMC1988787 Disease Relevance 0 Pain Relevance 0
Protocol 2: Acid-induced esophageal hypersensitivity was prevented by ketamine (AUC, P < 0.0001, ANOVA) without affecting foot pain thresholds (AUC, P = 0.06, ANOVA).
Neg (without) Regulation (affecting) of ANOVA in foot
4) Confidence 0.23 Published 2004 Journal Gastroenterology Section Body Doc Link 14988822 Disease Relevance 0.05 Pain Relevance 0
ANOVA was used to identify OTUs that were significantly affected by the dietary treatments in each of the ten subjects.
Regulation (affected) of ANOVA
5) Confidence 0.16 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2993935 Disease Relevance 0.08 Pain Relevance 0
Separate repeated-measures ANOVA on temporal alpha asymmetry change was performed for each type of Dan Tian Breathing (Passive versus Active), with time (baseline versus after one-month training) as within-subject factor and group (experimental versus control) as between-subject factor.
Regulation (change) of ANOVA
6) Confidence 0.15 Published 2011 Journal Evidence-based Complementary and Alternative Medicine : eCAM Section Body Doc Link PMC2957109 Disease Relevance 0 Pain Relevance 0
In addition, we determined changes from baseline for each intervention with one-way ANOVA tests followed by Dunnett's post test when the ANOVA P value was <0.05.
Regulation (value) of ANOVA
7) Confidence 0.14 Published 2008 Journal Diabetes Section Body Doc Link PMC2584124 Disease Relevance 0.15 Pain Relevance 0
The robustness of the DSS-associated gene signature was established by showing that the disease phenotype variable significantly affected expression levels of all the genes identified (multi-way ANOVA) and demonstrating the classifying capability of this gene signature using unsupervised hierarchical clustering and SVM/leave-one-out methods [35], [39], [40].
Regulation (affected) of ANOVA associated with dengue hemorrhagic fever and disease
8) Confidence 0.12 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2907396 Disease Relevance 2.48 Pain Relevance 0
The similar discrimination indexes (DIs) found in bees exposed at different periods to LIO and PHE and even between exposed and control bees (non-exposed bees) revealed no long-lasting effect of the passive olfactory experience (One-way ANOVA: LIOCS+LIO/CS-PHE: F3, 195?
Regulation (effect) of ANOVA in olfactory
9) Confidence 0.12 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2779852 Disease Relevance 0.07 Pain Relevance 0
Each of these neurons had a statistically significant effect of eye position according to ANOVA during both the baseline and stimulus periods (main effect, p?
Regulation (effect) of ANOVA in neurons
10) Confidence 0.09 Published 2010 Journal Frontiers in Integrative Neuroscience Section Body Doc Link PMC2936885 Disease Relevance 0 Pain Relevance 0
There was no significant change in CR latency-to-peak across sessions in the Control group (one-way ANOVA; F?
Neg (no) Regulation (change) of ANOVA
11) Confidence 0.03 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2912226 Disease Relevance 0.08 Pain Relevance 0
Values with the same letter are not significantly different at the P > 0.05 level (ANOVA followed by Tukey’s post-hoc test)


Neg (not) Regulation (different) of ANOVA
12) Confidence 0.03 Published 2010 Journal Ecotoxicology Section Body Doc Link PMC2995320 Disease Relevance 0 Pain Relevance 0
A one way ANOVA in the
Regulation (one) of ANOVA
13) Confidence 0.03 Published 2009 Journal Neural Plasticity Section Body Doc Link PMC2664642 Disease Relevance 0.16 Pain Relevance 0.11
In each statistical analysis, the effects of BPA and NP exposure were analyzed with respect to the control in the same ANOVA.
Spec (analyzed) Regulation (control) of ANOVA
14) Confidence 0.02 Published 2004 Journal Environ Health Perspect Section Body Doc Link PMC1247475 Disease Relevance 0.33 Pain Relevance 0.03
The repeated measure two way ANOVA model, controlling for time and the random effects of patients, detected a significant difference in pain intensity between placebo and ketorolac treated patients (p = 0.018, n = 24 & 20 for placebo and ketorolac, respectively).


Regulation (controlling) of ANOVA associated with pain and acular
15) Confidence 0.02 Published 2010 Journal Mol Pain Section Body Doc Link PMC2949722 Disease Relevance 1.23 Pain Relevance 1.03
Analysis of sessions 5–16 (Phases 2–4) within Control subjects revealed no significant change in CR frequency (Friedman 1-way repeated measures ANOVA, ?
Neg (no) Regulation (change) of ANOVA
16) Confidence 0.02 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2912226 Disease Relevance 0 Pain Relevance 0.04

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox